Reaction profile

The FDA adverse-event record for lack of efficacy (virus) - bovine viral diarrhoea virus

28 FDA reports name lack of efficacy (virus) - bovine viral diarrhoea virus, a lower-volume reaction in the CVM extract (VeDDRA 2812). Plate stamps and neighbourhood peers follow.

#2028 of 2,481
by report volume (all reactions)
28
reports citing this reaction
89.3%
death-coded share
Cattle
most-affected species

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Lack of efficacy (virus) - bovine viral diarrhoea virus has 28 reports now versus 25 in that prior snapshot: 3 more (12.0%).

Report change
+3
Death-coded reports
+3
Death-coded share
+1.3 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Lack of efficacy (virus) - bovine viral diarrhoea virus changes

FDA AER · VeDDRA plate

Code 2812 VOL-TRACE

VOL-TRACE · DEATH-HOT · LOWER-Q · PHOTO-FINISH · SPECIES-CATTLE · DRUG-LEAD · DESK-MID · BOOK-FULL

  • VOL-TRACE 28 reports
  • DEATH-HOT 89.3%
  • LOWER-Q #2028/2481
  • PHOTO-FINISH Absence seizure
  • SPECIES-CATTLE Cattle · 28
  • DRUG-LEAD Tulathromycin · 11
  • DESK-MID 6 breeds
  • BOOK-FULL 8/8 fields

Nearest volume peer: Absence seizure (±0 reports)

Upper-third death-coded share drives the outcome stamps on this plate; volume band, corpus rank, and co-report peers follow. Not a clinical diagnosis.

Lower-volume neighbourhood around Lack of efficacy - bovine viral diarrhoea virus

Lower-third volume poles plus nearest peers, not a full reaction corpus board reprint.

Vomiting · highest174348Absence seizure · near28Application site brui… · near28BILIRUBIN(DIRECT) HIG… · near28Cholangitis · near28Lack of efficacy (vir… · thi…28Urinary tract neoplas… · low…10
FDA AER report volume · neighbourhood around Lack of efficacy (virus) - bovine viral diarrhoea virus

Lack of efficacy (virus) - bovine viral diarrhoea virus: high death-coded share in the FDA AER plate

Signature read: Lack of efficacy (virus) - bovine viral diarrhoea virus's 89.3% death-coded share is among the highest in the openFDA reaction corpus. Report volume is lower-third scale: 28 named reports in the openFDA extract. Death-coded share is upper-third: 25 of 28 reports (89.3% of named reports). Nearest volume peer: Absence seizure (±0 reports). Lead species Cattle (28). Lead co-reported drug Tulathromycin (11).

Read these counts as reporting volume, not risk: per our methodology, A high death-coded share in FDA filings does not prove causation; co-reporting is voluntary temporal association only. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Cattle 28

Breeds Most Affected

Mixed (Cattle) 14
Cattle (other) 7
Cattle (unknown) 3
Aberdeen Angus 2
Salers 1
Holstein-Friesian also known as Holstein 1

Associated Drugs

Tulathromycin 11
Infectious Bovine Rhinotracheitis Virus(Ts), Rlb 106;Bovine Parainfluenza Virus 9
Bovine Viral Diarrhea Virus, Type 1, Strain Nadl-Sbvd, Msvx+1;Bovine Viral Diarr 7
Gamithromycin 6
Bovine Parainfluenza 3 Virus, Modified Live Virus + Bovine Respiratory Syncytial Virus, Modified Live Virus + Bovine Rhinotracheitis Virus, Modified Live Virus + Bovine Virus Diarrhea Type 1, Modified Live Virus + Bovine Virus Diarrhea Type 2, Modified Live Virus + Mannheimia Haemolytica Toxoid 5
Bovine Parainfluenza 3, Pi3 Ebk-1/Ebht-1 Strain Al-Im;Bovine Respiratory Syncyti 5
Ceftiofur Crystalline Free Acid 4
Bovine Parainfluenza 3 Virus, Modified Live Virus + Bovine Respiratory Syncytial Virus, Modified Live Virus + Bovine Rhinotracheitis Virus, Modified Live Virus + Bovine Virus Diarrhea, Modified Live Virus + Leptospira Canicola Bacterin + Leptospira Grippotyphosa Bacterin + Leptospira Hardjo Bacterin + Leptospira Icterohaemorrhagiae Bacterin + Leptospira Pomona Bacterin 3
Eprinomectin 3
Ketoprofen;Tulathromycin 3
Fenbendazol Suspension 2
Clos P*2/Cl Oth*4/H.Somnus Kb 2
Moxidectin 2
Bovine Parainfluenza 3, Pi3 Ebk-1/Ebht-1 Strain Al-Im;Infectious Bovine Rhinotra 2
Mannheimia Haemolytica, Strain Nl-1009 2
Bovine Parainfluenza 3 Virus, Modified Live Virus + Bovine Respiratory Syncytial Virus, Modified Live Virus + Bovine Rhinotracheitis Virus, Modified Live Virus + Bovine Virus Diarrhea Type 1, Modified Live Virus + Bovine Virus Diarrhea Type 2, Modified Live Virus 2
Mannheimia Haemolytica Toxoid 2
Haemophilus Somnus, 10555;Haemophilus Somnus, 8025 2
Oxfendazole 2
Mycoplasma Bovis 2

What to do with this reaction

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Lack of efficacy (virus) - bovine viral diarrhoea virus (#2028 of 2,481 by report volume); death-coded 89.3%. PlainBreed reaction plate · death-coded share stamp 89.3% · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →